Financials
Financial year 2025
Apotheek VAN der ELST Filip from Geraardsbergen, company number BE0442717797, closed financial year 2025 with a result of € 224,387 after tax. For that financial year Apotheek VAN der ELST Filip recorded a gross margin of € 508,166 and equity of € 736,336. Compared with financial year 2024, the result moved from € 239,759 to € 224,387. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 23, 2026.
€ 736,336
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 224,387
▼ 6% vs 2024
Profit after tax over the fiscal year.
€ 522,882
▲ 2% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 223,000 paid out
99 % of the profit went to the shareholders, mostly to FILI-PHARMA (100 % of the shares). That is where the money ends up.
People and assets in 2025
2.4
▲ 0.5 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 146,313
▲ 34% vs 2024
€ 61,000 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 3,562
▲ 71% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 148,076
▲ 7% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 35,901
▲ 7% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 353,591 | € 375,645 | € 492,513 | € 508,166 | ▲ 3% |
| Profit after taxes | € 157,182 | € 141,588 | € 239,759 | € 224,387 | ▼ 6% |
| Equity | € 727,602 | € 733,190 | € 734,949 | € 736,336 | |
| Total debts | € 518,428 | € 536,933 | € 529,925 | € 532,577 | ▲ 1% |
| Cash | € 433,739 | € 499,273 | € 513,220 | € 522,882 | ▲ 2% |
| Land & buildings | € 574,860 | € 517,024 | € 465,241 | € 405,316 | ▼ 13% |
| Retained profit | € 721,397 | € 726,985 | € 728,743 | € 730,131 | |
| Dividend | € 156,000 | € 136,000 | € 238,000 | € 223,000 | ▼ 6% |
| Balance sheet total | € 1,246,030 | € 1,270,123 | € 1,264,874 | € 1,268,913 | |
| Employees (FTE) | 1.9 | 2 | 1.9 | 2.4 | ▲ 0.5 |
Key figures of Apotheek VAN der ELST Filip, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Apotheek VAN der ELST Filip?
What happened at Apotheek VAN der ELST Filip in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 224,387 (▼ 6% vs 2024). Source: NBB ↗
- Fili-Pharma bv became a director. NBB
- New establishment in Geraardsbergen. KBO
- Start of the company according to the CBE. KBO
In short
From € 157,182 profit in 2022 to € 224,387 profit in 2025.
Paid € 205,725 in corporate taxes since 2022.
Best year ever: 2024, with € 239,759 profit.
On average € 211,700 of value added per employee in 2025.
A new publication or filing at Apotheek VAN der ELST Filip? We notify you, reason included.
Follow Apotheek VAN der ELST FilipDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of FILI-PHARMA comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
Apotheek VAN der ELST FilipBehind Apotheek VAN der ELST Filip is Fili-Pharma bv. The shares are held by FILI-PHARMA (100%).
Directors
According to the 2025 annual accounts
Director · represented by Filip Van der Elst
since 2010
Shareholders
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Wijngaardstraat 3-5
9500 Geraardsbergen
Wijngaardstraat 3 5
9500 Geraardsbergen
Active since 20 February 1991
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0442.717.797
- VAT number
- BE 0442.717.797
- Registered office
- Wijngaardstraat 3-5, 9500 Geraardsbergen
- Names & denominations
- Apotheek VAN der ELST Filip
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 14 December 1990
- Peppol
- Active · Active since 11 Sept 2025
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers